In the Matter of Certain Vaginal Ring Birth Control Devices; Notice of Investigation, 17444-17446 [2011-7295]

Download as PDF 17444 Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices management topics of interest to the Council raised during the planning process. These meetings are anticipated to occur monthly, and may occur as frequently as every two weeks during intensive phases of the planning process. Dates, times and agendas for additional meetings may be determined at future Advisory Council Meetings, and will be published in the Federal Register, announced through local media and on the BLM’s Web site for the Dominguez-Escalante planning effort, http://www.blm.gov/co/st/en/nca/ denca/denca_rmp.html. These meetings are open to the public. The public may present written comments to the Council. Each formal Council meeting will have time allocated at the beginning and end of each meeting for hearing public comments. Depending on the number of persons wishing to comment and time available, the time for individual, oral comments may be limited at the discretion of the chair. Helen M. Hankins, State Director. [FR Doc. 2011–7297 Filed 3–28–11; 8:45 am] BILLING CODE 4310–JB–P DEPARTMENT OF THE INTERIOR National Park Service [2253–665] Notice of Inventory Completion: Colorado Historical Society (History Colorado), Denver, CO National Park Service, Interior. Notice. AGENCY: jlentini on DSKJ8SOYB1PROD with NOTICES ACTION: Notice is here given in accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), 25 U.S.C. 3003, of the completion of an inventory of human remains in the possession and control of the Colorado Historical Society (History Colorado), Denver, CO. The human remains were removed from Howiri Ruin (LA 71), Taos County, NM. This notice is published as part of the National Park Service’s administrative responsibilities under NAGPRA, 25 U.S.C. 3003(d)(3). The determinations in this notice are the sole responsibility of the museum, institution, or Federal agency that has control of the Native American human remains. The National Park Service is not responsible for the determinations in this notice. A detailed assessment of the human remains was made by the Colorado Historical Society (History Colorado) VerDate Mar<15>2010 16:37 Mar 28, 2011 Jkt 223001 professional staff in consultation with representatives of the Hopi Tribe of Arizona; Navajo Nation, Arizona, New Mexico & Utah; Ohkay Owingeh, New Mexico; Pueblo of Acoma, New Mexico; Pueblo of Cochiti, New Mexico; Pueblo of Isleta, New Mexico; Pueblo of Jemez, New Mexico; Pueblo of Laguna, New Mexico; Pueblo of Nambe, New Mexico; Pueblo of Picuris, New Mexico; Pueblo of Pojoaque, New Mexico; Pueblo of San Ildefonso, New Mexico; Pueblo of Santa Ana, New Mexico; Pueblo of Santa Clara, New Mexico; Pueblo of Taos, New Mexico; Pueblo of Tesuque, New Mexico; Pueblo of Zia, New Mexico; Ysleta Del Sur Pueblo of Texas; and Zuni Tribe of the Zuni Reservation, New Mexico. The Kew Pueblo, New Mexico (formerly the Pueblo of Santo Domingo); Pueblo of Sandia, New Mexico; and Pueblo of San Felipe, New Mexico, were contacted for consultation purposes, but did not attend the consultation meetings. In 1958, human remains representing a minimum of one individual were removed from Howiri Ruin (LA 71), in Taos County, NM, by J.H. Gerault and Eugene Stigall. The remains were donated to the Huerfano County Museum in Colorado. In November 1989, the individual was transferred to the Colorado Historical Society. No known individual was identified. No associated funerary objects are present. Howiri Ruin is a large 15th century multi-storied Pueblo village near Ojo Caliente, NM. In 1958, Howiri Ruin had multiple owners, including private citizens and the State of New Mexico. It is not known if the individual was removed from private or public land within Howiri Ruin. Colorado Historical Society has accepted NAGPRA responsibilities for this individual. Osteological analysis by Colorado State University confirmed that the remains are of a Native American infant. Oral tradition and archeological evidence indicate the site was occupied by ancestors of present-day Northern Tewaspeaking Pueblos. Officials of the Colorado Historical Society have determined, pursuant to 25 U.S.C. 3001(9), that the human remains described above represent the physical remains of one individual of Native American ancestry. Officials of the Colorado Historical Society also have determined, pursuant to 25 U.S.C. 3001(2), that there is a relationship of shared group identity that can be reasonably traced between the Native American human remains and the Ohkay Owingeh, New Mexico; Pueblo of Nambe, New Mexico; Pueblo of Pojoaque, New Mexico; Pueblo of San Ildefonso, New Mexico; Pueblo of Santa PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 Clara, New Mexico; and Pueblo of Tesuque, New Mexico. Representatives of any other Indian Tribe that believes itself to be culturally affiliated with the human remains should contact Bridget Ambler, Curator of Material Culture, Colorado Historical Society (History Colorado), 1560 Broadway, Suite 400, Denver, CO 80202, telephone (303) 866–2303, before April 28, 2011. Repatriation of the human remains to the Ohkay Owingeh, New Mexico; Pueblo of Nambe, New Mexico; Pueblo of Pojoaque, New Mexico; Pueblo of San Ildefonso, New Mexico; Pueblo of Santa Clara, New Mexico; and Pueblo of Tesuque, New Mexico, may proceed after that date if no additional claimants come forward. The Colorado Historical Society (History Colorado) is responsible for notifying the Hopi Tribe of Arizona; Kewa Pueblo, New Mexico; Navajo Nation, Arizona, New Mexico & Utah; Ohkay Owingeh, New Mexico; Pueblo of Acoma, New Mexico; Pueblo of Cochiti, New Mexico; Pueblo of Isleta, New Mexico; Pueblo of Jemez, New Mexico; Pueblo of Laguna, New Mexico; Pueblo of Nambe, New Mexico; Pueblo of Picuris, New Mexico; Pueblo of Pojoaque, New Mexico; Pueblo of San Felipe, New Mexico; Pueblo of San Ildefonso, New Mexico; Pueblo of Sandia, New Mexico; Pueblo of Santa Ana, New Mexico; Pueblo of Santa Clara, New Mexico; Pueblo of Taos, New Mexico; Pueblo of Tesuque, New Mexico; Pueblo of Zia, New Mexico, Ysleta Del Sur Pueblo of Texas; and Zuni Tribe of the Zuni Reservation, New Mexico, that this notice has been published. Dated: March 23, 2011. Sherry Hutt, Manager, National NAGPRA Program. [FR Doc. 2011–7319 Filed 3–28–11; 8:45 am] BILLING CODE 4312–50–P INTERNATIONAL TRADE COMMISSION [Inv. No. 337–TA–768] In the Matter of Certain Vaginal Ring Birth Control Devices; Notice of Investigation U.S. International Trade Commission. ACTION: Institution of investigation pursuant to 19 U.S.C. 1337. AGENCY: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on February 25, 2011, under section 337 of the Tariff Act of 1930, as amended, 19 SUMMARY: E:\FR\FM\29MRN1.SGM 29MRN1 jlentini on DSKJ8SOYB1PROD with NOTICES Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices U.S.C. 1337, on behalf of Femina Pharma Incorporated of Miami, Florida. Letters supplementing the complaint were filed on March 11 and 15, 2011. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain vaginal ring birth control devices by reason of infringement of claim 1 of U.S. Patent No. 6,086,909 (‘‘the ‘909 patent’’). The complaint further alleges that an industry in the United States exists as required by subsection (a)(2) of section 337. The complainant requests that the Commission institute an investigation and, after the investigation, issue an exclusion order and cease and desist orders. ADDRESSES: The complaint, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street, SW., Room 112, Washington, DC 20436, telephone 202–205–2000. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on 202–205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server at http:// www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http://edis.usitc.gov. FOR FURTHER INFORMATION CONTACT: Office of Unfair Import Investigations, U.S. International Trade Commission, telephone (202) 205–2560. Authority: The authority for institution of this investigation is contained in section 337 of the Tariff Act of 1930, as amended, and in section 210.10 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.10 (2010). Scope Of Investigation: Having considered the complaint, the U.S. International Trade Commission, on March 23, 2011, ordered that— (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 1930, as amended, an investigation be instituted to determine whether there is a violation of subsection (a)(1)(B) of section 337 in the importation into the United States, the sale for importation, or the sale within the United States after VerDate Mar<15>2010 16:37 Mar 28, 2011 Jkt 223001 importation of certain vaginal ring birth control devices that infringe claim 1 of the ‘909 patent, and whether an industry in the United States exists as required by subsection (a)(2) of section 337; (2) Pursuant to Commission Rule 210.50(b)(1), 19 CFR 210.50(b)(1), the presiding administrative law judge shall take evidence or other information and hear arguments from the parties and other interested persons with respect to the public interest in this investigation, as appropriate, and provide the Commission with findings of fact and a recommended determination on this issue; (3) For the purpose of the investigation so instituted, the following are hereby named as parties upon which this notice of investigation shall be served: (a) The complainant is: Femina Pharma Incorporated, 3470 E. Coast Ave., Suite H502, Miami, FL 33137. (b) The respondents are the following entities alleged to be in violation of section 337, and are the parties upon which the complaint is to be served: Merck & Co., Inc., One Merck Drive, Whitehouse Station, NJ 08889; Schering Plough Corporation, 2000 Galloping Hill Road, Kenilworth, NJ 07033; Organon USA, Inc., 100 Rodolphe Street, Durham, North Carolina 27712; N.V. Organon, Molenstraat 110, Oss, Netherlands, 5340 BH; CVS Caremark Corporation, One CVS Drive, Woonsocket, RI 02895; CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895; Wal-Mart Stores, Inc., 702 S.W. 8th St., Bentonville, AR 72716; Walgreens Co., 200 Wilmont RD, Deerfield, IL 60015; The Canamerican Drugs Inc., d/b/a, http://www.77Canadapharmacy.com. http://www.medcentercanada.com. http://www.tigerdrugs.com . 77 Canada Pharmacy, 8–1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada. The Canamerican Global Inc., d/b/a, http://www.canamericanglobal.com, 77 Canada Pharmacy, 8–1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada; Canadian Med Service, d/b/a, http:// www.canadianmedservices.com, 77 Canada Pharmacy, 8–1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada; Panther Meds Inc., d/b/a, http:// www.panthermeds.com, 77 Canada Pharmacy, 8–1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada; Canada Drugs Online, d/b/a, http:// www.Canadadrugsonline.com, Unit PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 17445 #202A, 8322–130th Street, Surrey, British Columbia, Canada V3W 8J; Drug World Canada, d/b/a, http:// www.drugworldcanada.com, Unit #202A, 8322–130th Street, Surrey, British Columbia, Canada V3W 8J9; CanDrug Health Solutions Inc., d/b/a, http://www.candrug.com, Unit #202A,, 8322–130th Street, Surrey, British Columbia, Canada V3W 8J9; Big Mountain Drugs, d/b/a, http:// www.bigmountaindrugs.com, Unit #202A, 8322–130th Street, Surrey, British Columbia, Canada V3W 8J9; BestBuyRx.com, d/b/a, http:// www.bestbuyrx.com, Unit #202A, 8322–130th Street, Surrey, British Columbia, Canada V3W 8J9; Blue Sky Drugs, d/b/a, http:// www.Blueskydrugs.com, Unit #202A, 8322–130th Street, Surrey, British Columbia, Canada V3W 8J9; ABC Online Pharmacy, d/b/a, http:// www.abconlinepharmacy.com, 200– 7382 Winston Street, Burnaby, British Columbia, V5A 2G9 Canada; Canadadrugs.com LP, d/b/a, http:// www.Canadadrugs.com, 24 Terracon Place, Winnipeg, Manitoba, Canada R2J 4G7. North Drug Store, d/b/a, http:// www.northdrugstore.com, 266 Graham Avenue, P.O. Box 1074 Station Main, Winnipeg, Manitoba, R3C 2X4 Canada; Canada Pharmacy, d/b/a, http:// www.CanadaPharmacy.com, 477 Peace Portal Dr Suite #180, Blaine, WA 98230; (c) The Commission investigative attorney, party to this investigation, is the Office of Unfair Import Investigations, U.S. International Trade Commission, 500 E Street, SW., Suite 401, Washington, DC 20436; and (4) For the investigation so instituted, the Honorable Paul J. Luckern, Chief Administrative Law Judge, U.S. International Trade Commission, shall designate the presiding Administrative Law Judge. Responses to the complaint and the notice of investigation must be submitted by the named respondents in accordance with section 210.13 of the Commission’s Rules of Practice and Procedure, 19 CFR 210.13. Pursuant to 19 CFR 201.16(d)–(e) and 210.13(a), such responses will be considered by the Commission if received not later than 20 days after the date of service by the Commission of the complaint and the notice of investigation. Extensions of time for submitting responses to the complaint and the notice of investigation will not be granted unless good cause therefor is shown. Failure of a respondent to file a timely response to each allegation in the E:\FR\FM\29MRN1.SGM 29MRN1 17446 Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices complaint and in this notice may be deemed to constitute a waiver of the right to appear and contest the allegations of the complaint and this notice, and to authorize the administrative law judge and the Commission, without further notice to the respondent, to find the facts to be as alleged in the complaint and this notice and to enter an initial determination and a final determination containing such findings, and may result in the issuance of an exclusion order or a cease and desist order or both directed against the respondent. By order of the Commission. Issued: March 23, 2011. James R. Holbein, Acting Secretary to the Commission. [FR Doc. 2011–7295 Filed 3–28–11; 8:45 am] BILLING CODE P DEPARTMENT OF LABOR Office of the Secretary Agency Information Collection Activities; Submission for OMB Review; Comment Request; Notice of Alleged Safety or Health Hazards ACTION: Notice. The Department of Labor (DOL) hereby announces the submission of the Occupational Safety and Health Administration (OSHA) sponsored information collection request (ICR) titled, ‘‘Notice of Alleged Safety or Health Hazards,’’ to the Office of Management and Budget (OMB) for review and approval for continued use in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). DATES: Submit comments on or before April 28, 2011. ADDRESSES: A copy of this ICR, with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained from the RegInfo.gov Web site, http://www.reginfo.gov/ public/do/PRAMain, on the day following publication of this notice or by contacting Michel Smyth by telephone at 202–693–4129 (this is not a toll-free number) or sending an e-mail to DOL_PRA_PUBLIC@dol.gov. Submit comments about this request to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the Department of Labor, Occupational Safety and Health Administration (OSHA), Office of Management and Budget, Room 10235, jlentini on DSKJ8SOYB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:37 Mar 28, 2011 Jkt 223001 Washington, DC 20503, Telephone: 202–395–4816/Fax: 202–395–6881 (these are not toll-free numbers), e-mail: OIRA_submission@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: Contact Michel Smyth by telephone at 202–693–4129 (this is not a toll-free number) or by e-mail at DOL_PRA_PUBLIC@dol.gov. SUPPLEMENTARY INFORMATION: Respondents use the Notice of Alleged Safety or Health Hazards, Form OSHA– 7, to report unhealthful and/or unsafe conditions in the workplace to the OSHA. OSHAct section 8(f)(1) authorizes employee reports. The OSHA uses this information to evaluate the alleged hazards and to schedule an inspection. This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless it is currently approved by the OMB under the PRA and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information if the collection of information does not display a currently valid OMB control number. See 5 CFR 1320.5(a) and 1320.6. The DOL obtains OMB approval for this information collection under OMB Control Number 1218–0064. The current OMB approval is scheduled to expire on March 31, 2011; however, it should be noted that information collections submitted to the OMB receive a month-to-month extension while they undergo review. For additional information, see the related notice published in the Federal Register on January 13, 2011 (76 FR 2417). Interested parties are encouraged to send comments to the OMB, Office of Information and Regulatory Affairs at the address shown in the ADDRESSES section within 30 days of publication of this notice in the Federal Register. In order to help ensure appropriate consideration, comments should reference OMB Control Number 1218– 0064. The OMB is particularly interested in comments that: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Agency: Occupational Safety and Health Administration (OSHA). Title of Collection: Notice of Alleged Safety or Health Hazards, Form OSHA– 7. OMB Control Number: 1218–0064. Affected Public: Individuals and Households. Total Estimated Number of Respondents: 50,715. Total Estimated Number of Responses: 50,715. Total Estimated Annual Burden Hours: 13,414. Total Estimated Annual Costs Burden: $1,116. Dated: March 24, 2011. Michel Smyth, Departmental Clearance Officer. [FR Doc. 2011–7362 Filed 3–28–11; 8:45 am] BILLING CODE 4510–26–P DEPARTMENT OF LABOR Employment and Training Administration [TA–W–75,090] Wausau Daily Herald Advertising Production Division, a Subsidiary of Gannett Co., Inc.; Wausau, WI; Notice of Affirmative Determination Regarding Application for Reconsideration By application dated March 1, 2011 (received March 7, 2011), the petitioner requested administrative reconsideration of the negative determination regarding workers’ eligibility to apply for Trade Adjustment Assistance (TAA) applicable to workers and former workers of Wausau Daily Herald, Advertising Production Division, a subsidiary of Gannett Co., Inc., Wausau, Wisconsin (subject firm). The determination was issued on February 11, 2011. The Department’s Notice of Determination will soon be published in the Federal Register. The workers produce newspaper advertisements. The negative determination was based on the findings that, during the period E:\FR\FM\29MRN1.SGM 29MRN1

Agencies

[Federal Register Volume 76, Number 60 (Tuesday, March 29, 2011)]
[Notices]
[Pages 17444-17446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7295]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

 [Inv. No. 337-TA-768]


 In the Matter of Certain Vaginal Ring Birth Control Devices; 
Notice of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Institution of investigation pursuant to 19 U.S.C. 1337.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the 
U.S. International Trade Commission on February 25, 2011, under section 
337 of the Tariff Act of 1930, as amended, 19

[[Page 17445]]

U.S.C. 1337, on behalf of Femina Pharma Incorporated of Miami, Florida. 
Letters supplementing the complaint were filed on March 11 and 15, 
2011. The complaint alleges violations of section 337 based upon the 
importation into the United States, the sale for importation, and the 
sale within the United States after importation of certain vaginal ring 
birth control devices by reason of infringement of claim 1 of U.S. 
Patent No. 6,086,909 (``the `909 patent''). The complaint further 
alleges that an industry in the United States exists as required by 
subsection (a)(2) of section 337.
    The complainant requests that the Commission institute an 
investigation and, after the investigation, issue an exclusion order 
and cease and desist orders.

ADDRESSES: The complaint, except for any confidential information 
contained therein, is available for inspection during official business 
hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street, SW., Room 112, 
Washington, DC 20436, telephone 202-205-2000. Hearing impaired 
individuals are advised that information on this matter can be obtained 
by contacting the Commission's TDD terminal on 202-205-1810. Persons 
with mobility impairments who will need special assistance in gaining 
access to the Commission should contact the Office of the Secretary at 
202-205-2000. General information concerning the Commission may also be 
obtained by accessing its internet server at http://www.usitc.gov. The 
public record for this investigation may be viewed on the Commission's 
electronic docket (EDIS) at http://edis.usitc.gov.

FOR FURTHER INFORMATION CONTACT: Office of Unfair Import 
Investigations, U.S. International Trade Commission, telephone (202) 
205-2560.
    Authority: The authority for institution of this investigation is 
contained in section 337 of the Tariff Act of 1930, as amended, and in 
section 210.10 of the Commission's Rules of Practice and Procedure, 19 
CFR 210.10 (2010).
    Scope Of Investigation: Having considered the complaint, the U.S. 
International Trade Commission, on March 23, 2011, ordered that--
    (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 
1930, as amended, an investigation be instituted to determine whether 
there is a violation of subsection (a)(1)(B) of section 337 in the 
importation into the United States, the sale for importation, or the 
sale within the United States after importation of certain vaginal ring 
birth control devices that infringe claim 1 of the `909 patent, and 
whether an industry in the United States exists as required by 
subsection (a)(2) of section 337;
    (2) Pursuant to Commission Rule 210.50(b)(1), 19 CFR 210.50(b)(1), 
the presiding administrative law judge shall take evidence or other 
information and hear arguments from the parties and other interested 
persons with respect to the public interest in this investigation, as 
appropriate, and provide the Commission with findings of fact and a 
recommended determination on this issue;
    (3) For the purpose of the investigation so instituted, the 
following are hereby named as parties upon which this notice of 
investigation shall be served:
    (a) The complainant is: Femina Pharma Incorporated, 3470 E. Coast 
Ave., Suite H502, Miami, FL 33137.
    (b) The respondents are the following entities alleged to be in 
violation of section 337, and are the parties upon which the complaint 
is to be served:

Merck & Co., Inc., One Merck Drive, Whitehouse Station, NJ 08889;
Schering Plough Corporation, 2000 Galloping Hill Road, Kenilworth, NJ 
07033;
Organon USA, Inc., 100 Rodolphe Street, Durham, North Carolina 27712;
N.V. Organon, Molenstraat 110, Oss, Netherlands, 5340 BH;
CVS Caremark Corporation, One CVS Drive, Woonsocket, RI 02895;
CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895;
Wal-Mart Stores, Inc., 702 S.W. 8th St., Bentonville, AR 72716;
Walgreens Co., 200 Wilmont RD, Deerfield, IL 60015;
The Canamerican Drugs Inc., d/b/a, http://www.77Canadapharmacy.com. 
http://www.medcentercanada.com. http://www.tigerdrugs.com . 77 Canada 
Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada.
The Canamerican Global Inc., d/b/a, http://www.canamericanglobal.com, 
77 Canada Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9, 
Canada;
Canadian Med Service, d/b/a, http://www.canadianmedservices.com, 77 
Canada Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9, 
Canada;
Panther Meds Inc., d/b/a, http://www.panthermeds.com, 77 Canada 
Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada;
Canada Drugs Online, d/b/a, http://www.Canadadrugsonline.com, Unit 
202A, 8322-130th Street, Surrey, British Columbia, Canada V3W 
8J;
Drug World Canada, d/b/a, http://www.drugworldcanada.com, Unit 
202A, 8322-130th Street, Surrey, British Columbia, Canada V3W 
8J9;
CanDrug Health Solutions Inc., d/b/a, http://www.candrug.com, Unit 
202A,, 8322-130th Street, Surrey, British Columbia, Canada V3W 
8J9;
Big Mountain Drugs, d/b/a, http://www.bigmountaindrugs.com, Unit 
202A, 8322-130th Street, Surrey, British Columbia, Canada V3W 
8J9;
BestBuyRx.com, d/b/a, http://www.bestbuyrx.com, Unit 202A, 
8322-130th Street, Surrey, British Columbia, Canada V3W 8J9;
Blue Sky Drugs, d/b/a, http://www.Blueskydrugs.com, Unit 202A, 
8322-130th Street, Surrey, British Columbia, Canada V3W 8J9;
ABC Online Pharmacy, d/b/a, http://www.abconlinepharmacy.com, 200-7382 
Winston Street, Burnaby, British Columbia, V5A 2G9 Canada;
Canadadrugs.com LP, d/b/a, http://www.Canadadrugs.com, 24 Terracon 
Place, Winnipeg, Manitoba, Canada R2J 4G7.
North Drug Store, d/b/a, http://www.northdrugstore.com, 266 Graham 
Avenue, P.O. Box 1074 Station Main, Winnipeg, Manitoba, R3C 2X4 Canada;
Canada Pharmacy, d/b/a, http://www.CanadaPharmacy.com, 477 Peace Portal 
Dr Suite 180, Blaine, WA 98230;

    (c) The Commission investigative attorney, party to this 
investigation, is the Office of Unfair Import Investigations, U.S. 
International Trade Commission, 500 E Street, SW., Suite 401, 
Washington, DC 20436; and
    (4) For the investigation so instituted, the Honorable Paul J. 
Luckern, Chief Administrative Law Judge, U.S. International Trade 
Commission, shall designate the presiding Administrative Law Judge.
    Responses to the complaint and the notice of investigation must be 
submitted by the named respondents in accordance with section 210.13 of 
the Commission's Rules of Practice and Procedure, 19 CFR 210.13. 
Pursuant to 19 CFR 201.16(d)-(e) and 210.13(a), such responses will be 
considered by the Commission if received not later than 20 days after 
the date of service by the Commission of the complaint and the notice 
of investigation. Extensions of time for submitting responses to the 
complaint and the notice of investigation will not be granted unless 
good cause therefor is shown.
    Failure of a respondent to file a timely response to each 
allegation in the

[[Page 17446]]

complaint and in this notice may be deemed to constitute a waiver of 
the right to appear and contest the allegations of the complaint and 
this notice, and to authorize the administrative law judge and the 
Commission, without further notice to the respondent, to find the facts 
to be as alleged in the complaint and this notice and to enter an 
initial determination and a final determination containing such 
findings, and may result in the issuance of an exclusion order or a 
cease and desist order or both directed against the respondent.

    By order of the Commission.

    Issued: March 23, 2011.
James R. Holbein,
Acting Secretary to the Commission.
[FR Doc. 2011-7295 Filed 3-28-11; 8:45 am]
BILLING CODE P